Sydney Vital is a Translational Cancer Research Centre based at the Royal North Shore Hospital and funded by the Cancer Institute NSW and the University of Sydney. Their aim is to take cancer research from the laboratory bench and put this into practice. By doing so, they are able to provide patients with access to the latest medical discoveries and improve both their care and    outcomes. Their research partners include scientists and clinicians from The University of Sydney, Macquarie University & Medical School, The Kolling Institute, The University of Technology Sydney, Royal North Shore Hospital, Mater Hospital, and North Shore Private Hospital.

Besides funding outstanding cancer research, Sydney Vital also raises cancer research awareness to our local community via email, newsletters, Facebook, Twitter, YouTube and their website.  They also run regular ‘cancer events’ to disseminate cancer research findings and to engage with the local community.

Several of our Bill Walsh lab members have been fortunate to receive research and travel funding from Sydney Vital:

2019 to 2020 – A/Prof Viive Howell – 2019 Sydney Vital TCE Funding – “Value Adding to the Brain Tumour Bank”

2018 to 2019 – Sydney Vital Research Assistant Position (for SARRP Research Position Support) in the Inflammation Flagship

2017 to 2019 – Inflammation Flagship Fellowship to A/Prof Viive Howell and Dr Connie Diakos – 2017 recipient, Dr Kelly McKelvey

2015 to 2018 – Immuno-Oncology Pillar funding to A/Prof Viive Howell, Dr Emily Colvin and Dr Alex Menzies.